State Street’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.02M | Sell |
194,269
-6,856
| -3% | -$71.2K | ﹤0.01% | 3311 |
|
2025
Q1 | $2.65M | Buy |
201,125
+28,505
| +17% | +$376K | ﹤0.01% | 3144 |
|
2024
Q4 | $3.09M | Buy |
172,620
+15,125
| +10% | +$271K | ﹤0.01% | 3166 |
|
2024
Q3 | $2.54M | Buy |
157,495
+3,830
| +2% | +$61.7K | ﹤0.01% | 3246 |
|
2024
Q2 | $4.15M | Buy |
153,665
+84,104
| +121% | +$2.27M | ﹤0.01% | 3006 |
|
2024
Q1 | $1.36M | Sell |
69,561
-3,834
| -5% | -$74.8K | ﹤0.01% | 3395 |
|
2023
Q4 | $1.52M | Buy |
73,395
+5,620
| +8% | +$116K | ﹤0.01% | 3386 |
|
2023
Q3 | $2.16M | Buy |
67,775
+2,268
| +3% | +$72.1K | ﹤0.01% | 3296 |
|
2023
Q2 | $2.2M | Buy |
65,507
+51,450
| +366% | +$1.73M | ﹤0.01% | 3365 |
|
2023
Q1 | $586K | Hold |
14,057
| – | – | ﹤0.01% | 3690 |
|
2022
Q4 | $477K | Sell |
14,057
-83
| -0.6% | -$2.81K | ﹤0.01% | 3786 |
|
2022
Q3 | $696K | Buy |
14,140
+1,280
| +10% | +$63K | ﹤0.01% | 3669 |
|
2022
Q2 | $505K | Sell |
12,860
-46,840
| -78% | -$1.84M | ﹤0.01% | 3824 |
|
2022
Q1 | $2.2M | Buy |
59,700
+2,689
| +5% | +$99.2K | ﹤0.01% | 3527 |
|
2021
Q4 | $5.58M | Sell |
57,011
-90,655
| -61% | -$8.87M | ﹤0.01% | 3185 |
|
2021
Q3 | $18.4M | Buy |
147,666
+100,580
| +214% | +$12.6M | ﹤0.01% | 2533 |
|
2021
Q2 | $5.91M | Buy |
47,086
+7,061
| +18% | +$886K | ﹤0.01% | 3173 |
|
2021
Q1 | $5.43M | Buy |
40,025
+2,256
| +6% | +$306K | ﹤0.01% | 3016 |
|
2020
Q4 | $3.43M | Sell |
37,769
-1,716
| -4% | -$156K | ﹤0.01% | 3143 |
|
2020
Q3 | $2.94M | Buy |
39,485
+2,111
| +6% | +$157K | ﹤0.01% | 3045 |
|
2020
Q2 | $3.18M | Buy |
+37,374
| New | +$3.18M | ﹤0.01% | 2991 |
|
2019
Q4 | – | Sell |
-709
| Closed | -$37K | – | 3824 |
|
2019
Q3 | $37K | Buy |
709
+20
| +3% | +$1.04K | ﹤0.01% | 3736 |
|
2019
Q2 | $37K | Sell |
689
-9,968
| -94% | -$535K | ﹤0.01% | 3742 |
|
2019
Q1 | $758K | Buy |
10,657
+2,156
| +25% | +$153K | ﹤0.01% | 3392 |
|
2018
Q4 | $678K | Buy |
8,501
+4
| +0% | +$319 | ﹤0.01% | 3398 |
|
2018
Q3 | $3.96M | Buy |
8,497
+1,225
| +17% | +$571K | ﹤0.01% | 2973 |
|
2018
Q2 | $2.89M | Buy |
7,272
+567
| +8% | +$225K | ﹤0.01% | 3111 |
|
2018
Q1 | $2.05M | Sell |
6,705
-22
| -0.3% | -$6.73K | ﹤0.01% | 3160 |
|
2017
Q4 | $1.98M | Buy |
6,727
+443
| +7% | +$131K | ﹤0.01% | 3185 |
|
2017
Q3 | $3.44M | Buy |
6,284
+1,203
| +24% | +$659K | ﹤0.01% | 2965 |
|
2017
Q2 | $3.03M | Buy |
5,081
+2,755
| +118% | +$1.64M | ﹤0.01% | 2965 |
|
2017
Q1 | $997K | Buy |
2,326
+4
| +0.2% | +$1.72K | ﹤0.01% | 3262 |
|
2016
Q4 | $1.2M | Buy |
+2,322
| New | +$1.2M | ﹤0.01% | 3246 |
|